Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

ANKRD30B Inhibitors

ANKRD30B inhibitors are a class of chemical compounds designed to specifically target the ANKRD30B protein, which is a member of the ankyrin repeat domain-containing protein family. ANKRD30B contains multiple ankyrin repeat motifs, which are critical for mediating protein-protein interactions. These repeat motifs consist of a series of helix-loop-helix structures that create a stable interface for binding to other proteins, allowing ANKRD30B to play a key role in cellular processes such as signal transduction, structural assembly, and regulatory functions. Inhibitors of ANKRD30B are designed to disrupt these interactions by binding directly to the ankyrin repeat domains, thereby blocking the formation of essential protein complexes and altering the downstream cellular functions dependent on ANKRD30B.

Chemically, ANKRD30B inhibitors are diverse, including small molecules, peptides, and synthetic compounds. These inhibitors typically target specific regions within the ankyrin repeats, such as hydrophobic pockets or charged residues that are critical for the interaction between ANKRD30B and its protein partners. Some inhibitors work by mimicking the natural binding partners of ANKRD30B, effectively competing for the same binding sites and preventing the formation of functional protein complexes. Others induce conformational changes in ANKRD30B, destabilizing the structure of its ankyrin repeat domains and preventing proper protein folding or assembly. By inhibiting the interaction network mediated by ANKRD30B, these compounds serve as valuable tools for probing the protein's role in various cellular systems and understanding the molecular mechanisms that rely on ankyrin repeat domains for structural and functional stability.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

This histone deacetylase inhibitor could alter chromatin structure, potentially downregulating gene expression globally.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor, might decrease methylation and affect gene expression.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

Acts as a non-nucleoside DNA methyltransferase inhibitor, potentially leading to demethylation and altered gene expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Similar to 5-Azacytidine, it could affect DNA methylation and thereby gene expression patterns.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Another histone deacetylase inhibitor that might modify the expression of various genes.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Binds to DNA and could interfere with transcription factor binding, affecting gene expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

This compound binds to DNA and inhibits RNA polymerase, reducing gene transcription.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Known to inhibit transcriptional activity, which might affect gene expression broadly.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor, could indirectly affect protein synthesis and gene expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor, may alter signal transduction pathways that regulate gene expression.